Financhill
Back

Vera Therapeutics Quote, Financials, Valuation and Earnings

Buy
62

VERA
Vera Therapeutics

Last Price:
37.11
Seasonality Move:
41.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Vera Therapeutics Price Quote

$37.11

Vera Therapeutics Key Stats

Buy
62
Vera Therapeutics (VERA) is a Buy

Day range:
$36.55 - $39.39
52-week range:
$7.10 - $50.78
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
5.74%

Volume:
797K
Avg. volume:
849.3K
1-year change:
392.83%
Market cap:
$2B
Revenue:
$0
EPS:
$-2.05

How Much Does Vera Therapeutics Make?

Data Unavailable

Is Vera Therapeutics Growing As A Company?

Data Unavailable

Vera Therapeutics Stock Price Performance

  • Did Vera Therapeutics Stock Go Up Last Month?
    Vera Therapeutics share price went down by -7.11% last month
  • Did VERA's Share Price Rise Over The Last Year?
    VERA share price rose by 392.83% over the past 1 year

What Is Vera Therapeutics 52-Week High & Low?

Vera Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vera Therapeutics?

  • How Much Debt Does Vera Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vera Therapeutics Have?
    Cash and short term investments quarterly total is $403.7M
  • What Is Vera Therapeutics’s Book Value Per Share?
    Book value per share is 6.49

Is Vera Therapeutics Cash Flow Positive?

  • What Is VERA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$99.7M
  • What Is Vera Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $302.1M
  • What Is Vera Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$271M

Vera Therapeutics Return On Invested Capital

Data Unavailable

Vera Therapeutics Earnings Date & Stock Price

Vera Therapeutics Competitors

  • Who Are Vera Therapeutics's Competitors?
    Below is a list of companies who compete with Vera Therapeutics or are related in some way:
    • Equillium Inc (EQ)
    • Fate Therapeutics Inc (FATE)
    • Mersana Therapeutics Inc (MRSN)
    • Vertex Pharmaceuticals Inc (VRTX)

Vera Therapeutics Dividend Yield

Data Unavailable

Vera Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -3.21%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 56.70
Upside from Last Price: 52.79%

Major Shareholders

  • How many VERA shares are owned by institutional investors?
    71.9M VERA shares are owned by institutional investors
  • How many VERA shares are owned by insiders?
    510.9K VERA shares are owned by insiders